vs
Side-by-side financial comparison of ETHZilla Corp (ETHZ) and Moolec Science SA (MLEC). Click either name above to swap in a different company.
ETHZilla Corp is the larger business by last-quarter revenue ($4.1M vs $2.6M, roughly 1.6× Moolec Science SA). Moolec Science SA runs the higher net margin — -91.8% vs -5273.3%, a 5181.5% gap on every dollar of revenue.
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
ETHZ vs MLEC — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.1M | $2.6M |
| Net Profit | $-216.7M | $-2.4M |
| Gross Margin | — | -25.5% |
| Operating Margin | -5364.6% | -77.9% |
| Net Margin | -5273.3% | -91.8% |
| Revenue YoY | — | — |
| Net Profit YoY | -25803.8% | — |
| EPS (diluted) | $-16.80 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $4.1M | — | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | $0 | — | ||
| Q3 23 | $0 | $1.7M | ||
| Q3 22 | $-1.5K | — |
| Q3 25 | $-216.7M | — | ||
| Q4 24 | — | $-2.4M | ||
| Q3 24 | $-836.7K | — | ||
| Q3 23 | $-10.3M | $-1.6M | ||
| Q3 22 | $-21.5M | — |
| Q3 25 | — | — | ||
| Q4 24 | — | -25.5% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | 12.7% | ||
| Q3 22 | — | — |
| Q3 25 | -5364.6% | — | ||
| Q4 24 | — | -77.9% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | -130.3% | ||
| Q3 22 | 264007.3% | — |
| Q3 25 | -5273.3% | — | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | -91.4% | ||
| Q3 22 | 1398891.8% | — |
| Q3 25 | $-16.80 | — | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | $-5.43 | — | ||
| Q3 23 | $-24.53 | $-0.04 | ||
| Q3 22 | $-10.97 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $62.1M | $1.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $445.1M | $2.8M |
| Total Assets | $1.0B | $31.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $62.1M | — | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | — | ||
| Q3 23 | — | $853.6K | ||
| Q3 22 | — | — |
| Q3 25 | $445.1M | — | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | $3.7M | — | ||
| Q3 23 | $-149.3K | $8.9M | ||
| Q3 22 | $26.1M | — |
| Q3 25 | $1.0B | — | ||
| Q4 24 | — | $31.4M | ||
| Q3 24 | $10.5M | — | ||
| Q3 23 | $5.0M | $22.5M | ||
| Q3 22 | $34.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.4M | — |
| Free Cash FlowOCF − Capex | $-259.9M | — |
| FCF MarginFCF / Revenue | -6323.7% | — |
| Capex IntensityCapex / Revenue | 5923.8% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-16.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-239.9K | — | ||
| Q3 23 | $-1.8M | $-1.7M | ||
| Q3 22 | $-3.6M | — |
| Q3 25 | $-259.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q3 23 | — | $-1.8M | ||
| Q3 22 | — | — |
| Q3 25 | -6323.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q3 23 | — | -106.2% | ||
| Q3 22 | — | — |
| Q3 25 | 5923.8% | — | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | 6.0% | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
